Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study.

BACKGROUND AND PURPOSE Embolism is believed to be the major cause of stroke in patients with nonvalvular atrial fibrillation (NVAF). The detection of asymptomatic embolic signals (ES) in individuals with NVAF might allow identification of patients at high risk of stroke and monitoring of therapy in individual subjects. We determined the frequency of asymptomatic ES in patients with NVAF who were not taking warfarin. METHODS Bilateral transcranial Doppler recordings were made for 1 hour from the middle cerebral arteries of 111 successive patients with NVAF taking aspirin alone or no antithrombotic or anticoagulant therapy. Adequate recordings could be made in 86 patients. In 79 subjects, recordings were performed on a second occasion to study temporal variability. Recordings for a single hour were also made in 30 age-matched control subjects. RESULTS ES were detected in 13 (15.1%) of NVAF subjects but in no control subjects (P=0.02). ES were detected both in subjects with symptomatic NVAF (4 of 30 [13.1%], P=0.04 versus controls) and asymptomatic NVAF (9 of 56 [16.1%], P=0.02 versus controls). There was no correlation between the presence of ES and smoking status, diabetes, hypertension, aspirin use, aspirin dose, symptomatic status, left atrial size, left ventricular function, or the presence of left atrial thrombus detected on transthoracic echocardiography. Repeating the recording increased the number of patients with ES to 21 (26.6%). On considering the results of both recordings, again there was no association for either recording between the presence of ES and smoking status, diabetes, hypertension, aspirin use, aspirin dose, age, symptomatic status, left atrial size, or left ventricular function. On repeating the recording, in the symptomatic group only 2 patients (8%) changed status, in contrast to 15 (29%) in the asymptomatic group. CONCLUSIONS ES can be detected in patients with NVAF at a low frequency. Particularly in asymptomatic patients, ES show marked temporal variability. We found no correlation between the presence of previously reported clinical and echocardiographic markers of increased stroke risk and the presence of ES. This association requires further investigation before the clinical utility of this technique in patients with NVAF is decided.

[1]  H S Markus,et al.  Use of a decibel threshold in detecting Doppler embolic signals. , 1997, Stroke.

[2]  L. Valton,et al.  Asymptomatic cerebral embolic signals in patients with carotid stenosis. Correlation with appearance of plaque ulceration on angiography. , 1995, Stroke.

[3]  Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk , 1992, Annals of Internal Medicine.

[4]  L. Jäncke,et al.  Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. , 1995, Stroke.

[5]  A. Bolger,et al.  Incidence of Transcranial Doppler‐Detected Cerebral Microemboli in Patients Referred for Echocardiography , 1994, Stroke.

[6]  J M Bland,et al.  How good is intercenter agreement in the identification of embolic signals in carotid artery disease? , 1996, Stroke.

[7]  L. Murri,et al.  Carotid plaque features on angiography and asymptomatic cerebral microembolism , 1997, Acta neurologica Scandinavica.

[8]  J. Noth,et al.  Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism. A prospective study. , 1995, Stroke.

[9]  G. Albers,et al.  Transcranial Doppler-detected microemboli in patients with acute stroke. , 1995, Stroke.

[10]  K. Lees,et al.  Prevalence and Characteristics of Intracranial Microemboli Signals in Patients With Different Types of Prosthetic Cardiac Valves , 1994, Stroke.

[11]  K. Lees,et al.  Doppler Emboli Signals Vary According to Stroke Subtype , 1994, Stroke.

[12]  H. Steinmetz,et al.  Silent cerebral embolism caused by neurologically symptomatic high-grade carotid stenosis. Event rates before and after carotid endarterectomy. , 1993, Brain : a journal of neurology.

[13]  J. Nolan,et al.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all? , 1992, British heart journal.

[14]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[15]  M. Spencer,et al.  Detection of microemboli in patients with artificial heart valves using transcranial Doppler: preliminary observations. , 1993, The Journal of heart valve disease.

[16]  Merrill P. Spencer,et al.  Basic identification criteria of Doppler microembolic signals , 1995 .

[17]  H. Markus,et al.  Detection of circulating cerebral emboli using Doppler ultrasound in a sheep model , 1994, Journal of the Neurological Sciences.

[18]  Hugh S. Markus,et al.  Differentiation Between Different Pathological Cerebral Embolic Materials Using Transcranial Doppler in an In Vitro Model , 1993, Stroke.

[19]  J A Zivin,et al.  Detection of arterial emboli using Doppler ultrasound in rabbits. , 1991, Stroke.

[20]  H. Freund,et al.  Cerebral microembolism in symptomatic and asymptomatic high‐grade internal carotid artery stenosis , 1994, Neurology.

[21]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[22]  Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk , 1992, Annals of Internal Medicine.

[23]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[24]  S. Davis,et al.  Cerebral Microemboli in Atrial Fibrillation Detected by Transcranial Doppler Ultrasonography , 1996 .